The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PDSB FINANCIAL STATEMENTS

PDS Biotechnology Corp — balance sheet, income statement and cash flow trends

PDSBPDS Biotechnology Corp

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-40 M-20 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-15.1 K $ · -Infinity%Operating Income-27.8 M $ · -Infinity%Pre-tax Income-33.7 M $ · -Infinity%Net Income to Owners-33.7 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-15.1 K $—
Operating Income-27.8 M $—
EBITDA-27.1 M $—
Net Income to Owners-33.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
05 B10 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets8.8 B
  • Current Liabilities12.4 B $100%
  • Long-term Liabilities9.5 M $0%

Key Figures

YoY change
Total Assets8.8 B $+21,659.1%
Total Liabilities12.4 B $+50,425.4%
Total Equity-3.6 B $-22,529.7%
Cash & ST Investments5.6 B $+17,457.7%
Total Debt4.4 B $+23,440.6%
Net Debt-1.2 B $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-6 B-4 B-2 B0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 B-10 B0-7.2 B $Operating-13.9 B $Financing-21.1 B $Net Change

Key Figures

YoY change
Operating Cash Flow-7.2 B $—
Capital Expenditures13 $+160.0%
Free Cash Flow-7.2 B $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PDSB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.